Filing Details

Accession Number:
0001140361-16-088222
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-30 15:38:22
Reporting Period:
2016-11-10
Filing Date:
2016-11-30
Accepted Time:
2016-11-30 15:38:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1561387 Health Insurance Innovations Inc. HIIQ () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1366008 Sheldon Wang C/O Health Insurance Innovations, Inc.
15438 N. Florida Ave., Suite 201
Tampa FL 33613
Chief Technology Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2016-11-10 5,000 $6.90 280,001 No 4 S Direct
Class A Common Stock Disposition 2016-11-28 5,000 $11.90 275,001 No 4 S Direct
Class A Common Stock Disposition 2016-11-28 5,000 $12.90 270,001 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Class A Common Stock Stock Appreciation Rights $6.77 2021-05-25 84,000 84,000 Direct
Class A Common Stock Stock Appreciation Rights $6.77 2021-05-25 42,000 42,000 Direct
Class A Common Stock Stock Appreciation Rights $12.13 2021-07-14 10,000 10,000 Direct
Class A Common Stock Stock Appreciation Rights $4.95 2022-07-01 40,000 40,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2021-05-25 84,000 84,000 Direct
2021-05-25 42,000 42,000 Direct
2021-07-14 10,000 10,000 Direct
2022-07-01 40,000 40,000 Direct
Footnotes
  1. Transaction effected under a Rule 10b5-1 trading plan adopted by the reporting person in November 2016.
  2. These stock-settled stock appreciation rights were granted under the Plan and will vest as follows: (i) 42,000 on the first date on which the average trading price of the Company's Class A common stock is at or above $12.00 per share for the preceding 30 consecutive trading days, and (ii) 42,000 on the first date on which the average trading price of the Company's Class A common stock is at or above $16.00 per share for the preceding 30 consecutive trading days, all subject to the terms of the Plan and an award agreement under the Plan.
  3. These stock-settled stock appreciation rights were previously granted under the Plan and will vest (either wholly or partially) based on the extent to which certain financial performance targets established by the Company's Board of Directors are achieved for the 2016 fiscal year.
  4. These stock-settled stock appreciation rights were previously granted under the Issuer's Long-Term Incentive Plan and are scheduled to vest in increments of 20%, 20%, 20%, and 40% on successive anniversary dates of the grant, subject to the terms of the plan and an award agreement under the plan.
  5. These stock-settled stock appreciation rights were previously granted under the Issuer's Long-Term Incentive Plan (the "Plan") and are scheduled to vest in increments of 25%, 25%, and 50% on successive anniversary dates of the grant, subject to the terms of the Plan and an award agreement under the Plan.